PlainRecalls
FDA Drug Moderate Class II Terminated

Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Methylene Blue, 10 mg; Hyoscyamine Sulfate, 0.12 mg, 100 count, Rx only, Manufactured for: BUREL PHARMACEUTICALS, NDC 35573-315-10

Reported: December 7, 2016 Initiated: October 24, 2016 #D-0160-2017

Product Description

Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Methylene Blue, 10 mg; Hyoscyamine Sulfate, 0.12 mg, 100 count, Rx only, Manufactured for: BUREL PHARMACEUTICALS, NDC 35573-315-10

Reason for Recall

CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

Details

Recalling Firm
Burel Pharmaceuticals Inc
Units Affected
795 bottles
Distribution
Nationwide
Location
Richland, MS

Frequently Asked Questions

What product was recalled?
Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Methylene Blue, 10 mg; Hyoscyamine Sulfate, 0.12 mg, 100 count, Rx only, Manufactured for: BUREL PHARMACEUTICALS, NDC 35573-315-10. Recalled by Burel Pharmaceuticals Inc. Units affected: 795 bottles.
Why was this product recalled?
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Which agency issued this recall?
This recall was issued by the FDA Drug on December 7, 2016. Severity: Moderate. Recall number: D-0160-2017.